|
|
|
| Strategy |
 |
|
Biopharma Launch Strategies: What You Need to Know in 2020 |
In 2020 and beyond, succeeding in the new ecosystem means focusing on delivering value backed by data, tailored engagements with a diverse range of distinctly defined stakeholders, and monitoring the rapidly evolving healthcare space for new trends that will impact success, writes Bart Lombardi
… Read more |
|
|
|
| Audio |
 |
|
The Pharm Exec Podcast: Fabulous Pharma Females |
Barbara Ryan, founder of Barbara Ryan Advisors, a member of PharmExec’s Editorial Advisory Board, and the founder of Fabulous Pharma Females discusses the strong community she’s built providing women the opportunity to connect with each other and reinforce their shared commitment to one another
… Click here to listen |
|
|
|
| Industry update |
| //NeoPhore (Cambridge, UK) appointed Dr. Matthew Baker as Chief Executive Officer. Dr. Baker was previously Vice President of Immunology at the company.
//Adaptate Biotherapeutics (London, UK), a company focused on developing antibody-based therapeutics for modulation of gamma delta T cells, appointed Dr. Mihriban Tuna as Chief Scientific Officer.
//ADC Therapeutics (Lausanne, Switzerland) appointed Ron Squarer as Chairman of the Board of Directors and as an advisor to the company. Peter B. Corr, Ph.D., who has served as Chairman since the company's founding in June 2011, will remain on the board as a Director.
//Affimed (Heidelberg, Germany) announced the appointment of Dr. Arndt Schottelius as Chief Scientific Officer.
|
|
|
|
|
|
|
|
|
Register Now
